Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

被引：42
作者：
Meng, Lei [1 ,2 ]
Li, Xin-Yu [1 ,2 ]
Shen, Liang [1 ,2 ]
Ji, Hong-Fang [1 ,2 ]
机构：
[1] Shandong Univ Technol, Inst Biomed Res, Zibo, Shandong, Peoples R China
[2] Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Sch Life Sci, Zibo Key Lab New Drug Dev Neurodegenerat Dis, Zibo, Shandong, Peoples R China
来源：
TRENDS IN MOLECULAR MEDICINE | 2020年 / 26卷 / 06期
关键词：
AMYLOID-BETA-PROTEIN; GAMMA AGONIST PIOGLITAZONE; MILD COGNITIVE IMPAIRMENT; MODULATING TAU HYPERPHOSPHORYLATION; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; MOUSE MODEL; MEMORY IMPAIRMENT; INTRANASAL INSULIN; RECEPTOR AGONIST; PPAR-GAMMA;
D O I：
10.1016/j.molmed.2020.02.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) represent two major health burdens with steadily increasing prevalence and accumulating evidence indicates a close relationship between the two disorders. In view of their similar pathogenesis, the potential of T2DM drugs for the treatment of AD has attracted considerable attention in recent years, with inspiring outcomes. Here, we provide a comprehensive overview of the effects of a total of 14 individual drugs (among which are seven T2DM drug types) against AD. Further, we discuss the potential action mechanisms of these T2DM drugs against AD. We argue that these findings may open novel avenues for AD drug discovery, drug target identification, and cotreatment of the two disorders.
引用
收藏
页码：597 / 614
页数：18
相关论文
共 114 条
[41]   Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology [J].
Holubova, Martina ;
Hruba, Lucie ;
Popelova, Andrea ;
Bencze, Michal ;
Prazienkova, Veronika ;
Gengler, Simon ;
Kratochvilova, Helena ;
Haluzik, Martin ;
Zelezna, Blanka ;
Kunes, Jaroslav ;
Holscher, Christian ;
Maletinska, Lenka .
NEUROPHARMACOLOGY, 2019, 144 :377-387
[42]   Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study [J].
Imfeld, Patrick ;
Bodmer, Michael ;
Jick, Susan S. ;
Meier, Christoph R. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 (05) :916-921
[43]  
International Diabetes Federation, 2017, Diabetes-report. Idf diabetes atlas report, V8th
[44]   The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease [J].
Isik, Ahmet Turan ;
Soysal, Pinar ;
Yay, Adnan ;
Usarel, Cansu .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 123 :192-198
[45]   The Effect of Intrahippocampal Insulin Injection on Scopolamine-induced Spatial Memory Impairment and Extracellular Signal-regulated Kinases Alteration [J].
Jahanmahin, Ahmad ;
Abbasnejad, Zahra ;
Haghparast, Abbas ;
Ahmadiani, Abolhassan ;
Ghasemi, Rasoul .
BASIC AND CLINICAL NEUROSCIENCE, 2019, 10 (01) :23-36
[46]   Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease [J].
Jose Ramos-Rodriguez, Juan ;
Spires-Jones, Tara ;
Pooler, Amy M. ;
Maria Lechuga-Sancho, Alfonso ;
Bacskai, Brian J. ;
Garcia-Alloza, Monica .
MOLECULAR NEUROBIOLOGY, 2017, 54 (05) :3428-3438
[47]   Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes [J].
Khalaf, Samar S. ;
Hafez, Mohamed M. ;
Mehanna, Eman T. ;
Mesbah, Noha M. ;
Abo-Elmatty, Dina M. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (06) :685-695
[48]   Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures [J].
Kim, Dong-Hou ;
Huh, Jae-Wan ;
Jang, Mi ;
Suh, Jung-Hyun ;
Kim, Tae-Wan ;
Park, Jeong-Su ;
Yoon, Seung-Yong .
NEUROBIOLOGY OF DISEASE, 2012, 46 (01) :52-58
[49]   Mid-life and late-life vascular risk factors and dementia in Korean men and women [J].
Kimm, H. ;
Lee, P. H. ;
Shin, Y. J. ;
Park, K. S. ;
Jo, J. ;
Lee, Y. ;
Kang, H. C. ;
Jee, S. H. .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2011, 52 (03) :E117-E122
[50]   Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study [J].
Koenig, Aaron M. ;
Mechanic-Hamilton, Dawn ;
Xie, Sharon X. ;
Combs, Martha F. ;
Cappola, Anne R. ;
Xie, Long ;
Detre, John A. ;
Wolk, David A. ;
Arnold, Steven E. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2017, 31 (02) :107-113
12345678910